Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma

A major molecular pathway of genetic instability in cancer is DNA mismatch repair deficiency. High-level microsatellite instability (MSI-H) is currently the best predictor of responsiveness towards immune checkpoint blockade. Data about the prevalence of high-level microsatellite instability in chol...

Full description

Saved in:
Bibliographic Details
Main Authors: Goeppert, Benjamin (Author) , Rössler, Stephanie (Author) , Renner, Marcus (Author) , Singer, Stephan (Author) , Mehrabi, Arianeb (Author) , Vogel, Monika Nadja (Author) , Pathil-Warth, Anita (Author) , Busch, Elena (Author) , Köhler, Bruno Christian (Author) , Springfeld, Christoph (Author) , Pfeiffenberger, Jan (Author) , Rupp, Christian (Author) , Weiss, Karl Heinz (Author) , Schirmacher, Peter (Author) , Knebel Doeberitz, Magnus von (Author) , Kloor, Matthias (Author)
Format: Article (Journal)
Language:English
Published: 2019
In: British journal of cancer
Year: 2018, Volume: 120, Issue: 1, Pages: 109-114
ISSN:1532-1827
DOI:10.1038/s41416-018-0199-2
Online Access:Verlag, Volltext: https://doi.org/10.1038/s41416-018-0199-2
Verlag, Volltext: https://www.nature.com/articles/s41416-018-0199-2
Get full text
Author Notes:Benjamin Goeppert, Stephanie Roessler, Marcus Renner, Stephan Singer, Arianeb Mehrabi, Monika Nadja Vogel, Anita Pathil, Elena Czink, Bruno Köhler, Christoph Springfeld, Jan Pfeiffenberger, Christian Rupp, Karl Heinz Weiss, Peter Schirmacher, Magnus von Knebel Doeberitz and Matthias Kloor
Description
Summary:A major molecular pathway of genetic instability in cancer is DNA mismatch repair deficiency. High-level microsatellite instability (MSI-H) is currently the best predictor of responsiveness towards immune checkpoint blockade. Data about the prevalence of high-level microsatellite instability in cholangiocarcinoma (CCA) has been conflicting. We employed a cohort comprising 308 Western-world, non-liver fluke-associated CCAs (159 intrahepatic, 106 perihilar, and 43 distal). We analysed the mononucleotide microsatellite instability marker panel consisting of BAT25, BAT26, and CAT25 and detected MSI-H in 4/308 CCAs (1.3%). Patients affected by MSI-H CCA had mostly an atypical histomorphology (p = 0.004), showed a longer overall survival, although having a high tumour stage, and were of younger age. Correlation analysis of microsatellite instability status with tumour-infiltrating immune cells, MHC I, and PD-L1 expression in the same cholangiocarcinoma cohort showed higher numbers of CD8 + T cells, FOXP3 + regulatory T cells, CD20 + B cells and high or at least moderate MHC I expression levels in MSI-H CCAs. Even though the overall number of MSI-H CCAs is low, the dismal prognosis of the disease and the therapeutic option of immune checkpoint blockade in the respective patients justify MSI testing of cholangiocarcinoma, particularly in younger patients showing an atypical histomorphology.
Item Description:Published: 31 October 2018
Gesehen am 08.05.2019
Physical Description:Online Resource
ISSN:1532-1827
DOI:10.1038/s41416-018-0199-2